Literature DB >> 17408635

H-ras inhibits RhoA/ROCK leading to a decrease in the basal tone in the internal anal sphincter.

Márcio A F de Godoy1, Chirag A Patel, Scott A Waldman, Motoya Katsuki, Raymond F Regan, Satish Rattan.   

Abstract

BACKGROUND & AIMS: The present studies evaluated the role of H-ras and its implications in the RhoA/Rho kinase (ROCK) pathway in regulating basal tone in the internal anal sphincter (IAS).
METHODS: Studies were performed in the IAS from the wild-type (H-ras(+/+)) and knock-out (H-ras(-/-)) mice. The basal tone of smooth muscle strips was measured by isometric force transducers. Length of smooth muscle cells (SMC) isolated from the IAS in the basal state was determined by phase contrast microscopy. Experiments were repeated in the presence of Y 27632, a ROCK inhibitor. Involvement of the RhoA/ROCK machinery was analyzed by reverse-transcription polymerase chain reaction, Western blot, and immunocytochemistry. Reversal of H-ras knock-out effect was evaluated by transfection of SMCs with the constitutively activated (G12V) mutant.
RESULTS: Basal tone of the H-ras(-/-) IAS was significantly higher and resistant to relaxation by Y 27632, compared with the H-ras(+/+) IAS. Similarly, the length of SMCs from H-ras(-/-) IAS was significantly shorter. Y 27632 eliminated this difference. RhoA immunoreactivity shifted from cytoplasm to plasma membrane in H-ras(-/-) SMCs, a change typically associated with contraction. Further, SMCs from H-ras(-/-) mice exhibited higher levels of the contractile proteins ROCK II, phosphorylated-MYPT(1) and phosphorylated-MLC(20). Transfection with the G12V mutant increased the length of H-ras(-/-) cells. Conversely, the dominant negative H-ras (S17N) mutant decreased the length of H-ras(+/+) cells.
CONCLUSIONS: H-ras negatively regulates basal tone in the IAS by inhibiting RhoA/Rho-kinase machinery. Studies may have significant relevance in the pathophysiology and therapy of certain anorectal motility disorders associated with the IAS dysfunction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17408635     DOI: 10.1053/j.gastro.2007.01.043

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  6 in total

Review 1.  Role of rho kinase in the functional and dysfunctional tonic smooth muscles.

Authors:  Márcio A F de Godoy; Satish Rattan
Journal:  Trends Pharmacol Sci       Date:  2011-04-15       Impact factor: 14.819

2.  Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis.

Authors:  M Hennenberg; J Trebicka; C Stark; A Z Kohistani; J Heller; T Sauerbruch
Journal:  Br J Pharmacol       Date:  2009-03-26       Impact factor: 8.739

Review 3.  Beta-Arrestins in the Treatment of Heart Failure Related to Hypertension: A Comprehensive Review.

Authors:  Ahmed Rakib; Taslima Akter Eva; Saad Ahmed Sami; Saikat Mitra; Iqbal Hossain Nafiz; Ayan Das; Abu Montakim Tareq; Firzan Nainu; Kuldeep Dhama; Talha Bin Emran; Jesus Simal-Gandara
Journal:  Pharmaceutics       Date:  2021-06-05       Impact factor: 6.321

4.  Evidence for the presence and release of BDNF in the neuronal and non-neuronal structures of the internal anal sphincter.

Authors:  Arjun Singh; Jagmohan Singh; Satish Rattan
Journal:  Neurogastroenterol Motil       Date:  2021-02-24       Impact factor: 3.960

Review 5.  Regulation of smooth muscle contraction by monomeric non-RhoA GTPases.

Authors:  Bingsheng Li; Ruixiao Wang; Yiming Wang; Christian G Stief; Martin Hennenberg
Journal:  Br J Pharmacol       Date:  2020-07-19       Impact factor: 8.739

Review 6.  Ionic Conductance(s) in Response to Post-junctional Potentials.

Authors:  Sang Don Koh; Poong-Lyul Rhee
Journal:  J Neurogastroenterol Motil       Date:  2013-10-07       Impact factor: 4.924

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.